Health
This Small Canadian Drugmaker Wants to Make J&J Vaccines for Poor Nations. It Needs More Than a Patent Waiver. – Kaiser Health News
All agree that covid vaccines are urgently needed to stop the pandemic, but simply waiving patents fails to provide technological know-how and address supply chain…
Sarah Jane Tribble, Kaiser Health News and Arthur AllenBiolyse Pharma Corp., which makes injectable cancer drugs, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit.
Use Our Content
It can be republished for free.
Watching the covid death toll climb, the company decided its new production lines and equipment could be converted to making vaccines for poorer countries without the means to do so.
John Fulton, a consultant for the Canadian company,…
-
General19 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General21 hours agoRestaurants on the brink as business failures plateau
-
General18 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General10 hours agoThree maps that show the scale of the NSW flood disaster